AGRX stock news

The Zacks Analyst Blog Highlights: Barrett Business Services, Hibbett Sports, Construction Partners, Agile Therapeutics and Boot Barn Read more
Agile Therapeutics (AGRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Read more
Agile's contraceptive product candidate, Twirla, has an FDA AdCom scheduled for October 30th. Investors should have a game plan for their AGRX position as we ap Read more
PRINCETON, N.J., May 09, 2019 -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Chairman and Chief Executive Officer, Al. Read more

Agile Therapeutics misses by $0.03

09:04pm, Thursday, 02'nd May 2019
Read more
Here we will take a look at several key ratios for Agile Therapeutics, Inc. (NasdaqCM:AGRX), starting with the Book to Market (BTM) ratio. Value investors seek stocks with high BTMs for their portfoli Read more
Based on the lastest quarterly filings, institutions continue to be large stakeholders in Agile Therapeutics, Inc. (NASDAQ:AGRX). The big banks are holding 35.20% of the shares while company insiders Read more
Agile Therapeutics Inc (NASDAQ:AGRX) Director Abhijeet J. Lele bought 20,000 shares of the firm’s stock in a transaction on Friday, March 29th. The stock was purchased at an average cost of $1.54 pe Read more
Today, a Director at Agile Therapeutics (AGRX), Abhijeet Lele, bought shares of AGRX for $30.8K. The post A Director at Agile Therapeutics (AGRX) is Buying Shares appeared first on Smarter Analyst . Read more
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) and Agile Therapeutics Inc. (NASDAQ:AGRX) compete with each other in the Drugs – Generic sector. We will analyze and compare their profitability, analyst r Read more
The +DI is presently above the -DI on shares of Agile Therap (AGRX). Traders focusing on these levels may be watching for the stock to be gaining bullish momentum. Some investors may be struggling aft Read more
Nippon Piston Ring Co., Ltd. (TSE:6461) currently has a current ratio of 1.19. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of Read more
Sentiment for Algorx Pharmaceuticals Inc (NASDAQ:AGRX) Algorx Pharmaceuticals Inc (NASDAQ:AGRX) institutional sentiment decreased to 0.46 in 2018 Q4. Its down -0.29, from 0.75 in 2018Q3. The ratio dro Read more

Proudly made at